The efficacy and safety of ciprofol use for the induction of general anesthesia in patients undergoing gynecological surgery: a prospective randomized controlled study
- PMID: 35922771
- PMCID: PMC9347095
- DOI: 10.1186/s12871-022-01782-7
The efficacy and safety of ciprofol use for the induction of general anesthesia in patients undergoing gynecological surgery: a prospective randomized controlled study
Abstract
Background: Ciprofol is a recently developed, short-acting γ-aminobutyric acid receptor agonist sedative that is more potent than propofol, but there have been few clinical studies of this agent to date. Here, we sought to examine the safety and efficacy of ciprofol use for the induction of general anesthesia in individuals undergoing gynecological surgery.
Methods: Women between the ages of 18 and 60 years (ASA physical status 1 or 2) who were scheduled to undergo elective gynecological surgery under general anesthesia were randomly assigned to two equally sized groups in which anesthesia induction was performed using either ciprofol or propofol. General anesthesia induction success rates were the primary outcome for this study, while secondary outcomes included changes in BIS during the 10 min following the first administration of the study drug, the duration of successful induction, and adverse event incidence.
Results: A total of 120 women were included in the study. A 100% rate of successful induction was achieved in both the ciprofol and propofol groups, with no significant differences between these groups with respect to the duration of successful induction (34.8 ± 15.5 s vs 35.4 ± 9.5 s, P = 0.832), the time to the disappearance of the eyelash reflex (33.7 ± 10.6 s vs 34.0 ± 6.5 s, P = 0.860), or tracheal intubation (58.2 ± 31.1 s vs 53.9 ± 25.4 s, P = 0.448). Adverse event rates, including intubation responses, were significantly lower in the ciprofol group as compared to the propofol group(20% vs 48.33%, P = 0.0019). Ciprofol was associated with reduced injection pain relative to propofol (16.7% vs 58.3%, P < 0.001).
Conclusions: Ciprofol exhibits comparable efficacy to that of propofol when used for the induction of general anesthesia in individuals undergoing gynecological surgery and is associated with fewer adverse events.
Keywords: Ciprofol; General anesthesia; Gynecological surgery; Induction.
© 2022. The Author(s).
Conflict of interest statement
The authors declare that they have no conflicts of interest.
Figures



Similar articles
-
Effects of ciprofol for the induction of general anesthesia in patients scheduled for elective surgery compared to propofol: a phase 3, multicenter, randomized, double-blind, comparative study.Eur Rev Med Pharmacol Sci. 2022 Mar;26(5):1607-1617. doi: 10.26355/eurrev_202203_28228. Eur Rev Med Pharmacol Sci. 2022. PMID: 35302207 Clinical Trial.
-
Efficacy and safety of ciprofol for general anesthesia induction in female patients with frailty: a prospective randomized controlled trial.BMC Anesthesiol. 2024 Oct 31;24(1):396. doi: 10.1186/s12871-024-02776-3. BMC Anesthesiol. 2024. PMID: 39482601 Free PMC article. Clinical Trial.
-
Bispectral Index-Monitored Anesthesia Induction in Older Adults Undergoing Elective Surgery: Comparing Ciprofol and Propofol in a Prospective, Single-Center, Double-Blind, Randomized Controlled Study.Drug Des Devel Ther. 2024 Nov 5;18:4993-5003. doi: 10.2147/DDDT.S484532. eCollection 2024. Drug Des Devel Ther. 2024. PMID: 39525043 Free PMC article. Clinical Trial.
-
Efficacy and safety of Ciprofol compared with Propofol during general anesthesia induction: A systematic review and meta-analysis of randomized controlled trials (RCT).J Clin Anesth. 2024 Jun;94:111425. doi: 10.1016/j.jclinane.2024.111425. Epub 2024 Feb 26. J Clin Anesth. 2024. PMID: 38412619
-
Ciprofol: A Novel Alternative to Propofol in Clinical Intravenous Anesthesia?Biomed Res Int. 2023 Jan 19;2023:7443226. doi: 10.1155/2023/7443226. eCollection 2023. Biomed Res Int. 2023. PMID: 36714027 Free PMC article. Review.
Cited by
-
Ciprofol versus propofol for long-term sedation in mechanically ventilated patients with sepsis: a randomized controlled trial.BMC Anesthesiol. 2025 Apr 9;25(1):161. doi: 10.1186/s12871-025-03042-w. BMC Anesthesiol. 2025. PMID: 40205333 Free PMC article. Clinical Trial.
-
The Effects of Different Ciprofol Doses on Hemodynamics During Anesthesia Induction in Patients Undergoing Cardiac Surgery: A Randomized, Double-Blind, Controlled Study.Drug Des Devel Ther. 2025 Mar 11;19:1671-1679. doi: 10.2147/DDDT.S505772. eCollection 2025. Drug Des Devel Ther. 2025. PMID: 40098910 Free PMC article. Clinical Trial.
-
Influences of Propofol, Ciprofol and Remimazolam on Dreaming During Anesthesia for Gastrointestinal Endoscopy: A Randomized Double-Blind Parallel-Design Trial.Drug Des Devel Ther. 2024 May 29;18:1907-1915. doi: 10.2147/DDDT.S455915. eCollection 2024. Drug Des Devel Ther. 2024. PMID: 38828026 Free PMC article. Clinical Trial.
-
A Common Neuronal Ensemble in the Lateral Habenula Regulates Ciprofol Anesthesia in Mice.Pharmaceuticals (Basel). 2024 Mar 11;17(3):363. doi: 10.3390/ph17030363. Pharmaceuticals (Basel). 2024. PMID: 38543149 Free PMC article.
-
Efficacy and safety of ciprofol versus propofol for anesthesia induction in adult patients received elective surgeries: a meta‑analysis.BMC Anesthesiol. 2024 Mar 7;24(1):93. doi: 10.1186/s12871-024-02479-9. BMC Anesthesiol. 2024. PMID: 38454362 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous